Pharmaids Pharmaceuticals Ltd — Important, 07-07-2026: Company Update

Pharmaids Pharmaceuticals has confirmed its compliance with dematerialization rules for the quarter ending June 30, 2026. The company’s Registrar and Share Transfer Agent certified that all physical shares received for dematerialization were processed efficiently. This includes proper verification, cancellation, and updating depository records (NSDL/CDSL) as owners within the required 15-day timeframe. This ensures smooth and timely conversion of physical shares into electronic form for investors, upholding transparency in share registry operations.